BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2906173)

  • 21. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.
    Mülsch A; Bauersachs J; Schäfer A; Stasch JP; Kast R; Busse R
    Br J Pharmacol; 1997 Feb; 120(4):681-9. PubMed ID: 9051308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of nitrate tolerance with concomitant administration of hydralazine.
    Elkayam U
    Can J Cardiol; 1996 May; 12 Suppl C():17C-21C. PubMed ID: 8634919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhaled nitric oxide decreases pulmonary soluble guanylate cyclase protein levels in 1-month-old lambs.
    Thelitz S; Bekker JM; Ovadia B; Stuart RB; Johengen MJ; Black SM; Fineman JR
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1285-92. PubMed ID: 15115984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is there an optimal prophylactic nitrate therapy?
    Olsson G; Allgén J
    Eur Heart J; 1991 May; 12 Suppl A():21-3. PubMed ID: 1874271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Randomized, double-blind, placebo-controlled study of supplemental vitamin E on attenuation of the development of nitrate tolerance].
    Watanabe H; Kakihana M; Ohtsuka S; Sugishita Y
    J Cardiol; 1998 Mar; 31(3):173-81. PubMed ID: 9557281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin E deficiency accelerates nitrate tolerance via a decrease in cardiac P450 expression and increased oxidative stress.
    Minamiyama Y; Takemura S; Hai S; Suehiro S; Okada S
    Free Radic Biol Med; 2006 Mar; 40(5):808-16. PubMed ID: 16520233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nitrates and NO release: contemporary aspects in biological and medicinal chemistry.
    Thatcher GR; Nicolescu AC; Bennett BM; Toader V
    Free Radic Biol Med; 2004 Oct; 37(8):1122-43. PubMed ID: 15451053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioactivation of organic nitrates and the mechanism of nitrate tolerance.
    Klemenska E; Beresewicz A
    Cardiol J; 2009; 16(1):11-9. PubMed ID: 19130411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical significance of nitrate tolerance].
    Maire R; Hess OM; Krayenbühl HP
    Schweiz Rundsch Med Prax; 1987 Apr; 76(18):480-4. PubMed ID: 3589306
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of trimetazidine plus sildenafil to chronic nitrates in the control of myocardial ischemia during sexual activity in patients with coronary artery disease.
    Rosano GM; Marazzi G; Patrizi R; Cerquetani E; Vitale C; Volterrani M; Fini M; Mercuro G
    Am J Cardiol; 2005 Feb; 95(3):327-31. PubMed ID: 15670539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Organic nitrates in cardiovascular disease.
    Bode-Böger SM; Kojda G
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(3):307-20. PubMed ID: 16191399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of nitrate-induced vasodilatation and tolerance.
    Kukovetz WR; Holzmann S
    Eur J Clin Pharmacol; 1990; 38 Suppl 1():S9-14. PubMed ID: 1972361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Some pharmacological properties of organic nitrates.
    Osnes JB
    Scand J Clin Lab Invest Suppl; 1984; 173():19-25. PubMed ID: 6098958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nitrate tolerance: a clinically significant problem?
    Rudolph W; Blasini R
    Herz; 1984 Jun; 9(3):115-22. PubMed ID: 6430765
    [No Abstract]   [Full Text] [Related]  

  • 35. Interactions between organic nitrates and thiol groups.
    Abrams J
    Am J Med; 1991 Sep; 91(3C):106S-112S. PubMed ID: 1928200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monitoring white blood cell mitochondrial aldehyde dehydrogenase activity: implications for nitrate therapy in humans.
    Wenzel P; Schulz E; Gori T; Ostad MA; Mäthner F; Schildknecht S; Göbel S; Oelze M; Stalleicken D; Warnholtz A; Münzel T; Daiber A
    J Pharmacol Exp Ther; 2009 Jul; 330(1):63-71. PubMed ID: 19346443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Principles and rules of the use of nitrates].
    Garcia Moll M
    Ann Cardiol Angeiol (Paris); 1997; 46(7):399-405. PubMed ID: 9452773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between pharmacokinetics and pharmacodynamics of organic nitrates.
    Jähnchen E
    Z Kardiol; 1986; 75 Suppl 3():12-5. PubMed ID: 3099483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tolerance to organic nitrates: evidence, mechanisms, clinical relevance, and strategies for prevention.
    Elkayam U
    Ann Intern Med; 1991 Apr; 114(8):667-77. PubMed ID: 2003715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nitrate tolerance from a biochemical point of view.
    Axelsson KL; Ahlner J
    Drugs; 1987; 33 Suppl 4():63-8. PubMed ID: 3040374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.